Aref Al-Kali

103PUBLICATIONS
250CO-AUTHORS
Digital healthHaematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapyPervasive computing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (103)

|Sep 25, 2026
Evaluation of Modern Hematology-Oncology Home-Call: Optimizing Patient Care, Physician Wellbeing, and Trainee Education.

|Sep 18, 2026
Venetoclax Plus Hypomethylating Agent for 7- Versus 14- Versus 21- Versus 28-Day Cycles in Newly-Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk-Stratified Analysis in 540 Patients.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Aug 23, 2026
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.

|Aug 07, 2026
Clinics and Clicks: Optimizing Hematology Care Delivery and Workflows in the Digital Era.

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

Pageof 18

Frequent Collaborators

60 joint publications

Naseema Gangat

59 joint publications

Mrinal S Patnaik

47 joint publications

Ayalew Tefferi

44 joint publications

Mithun Vinod Shah